Cell therapy for rate control in atrial fibrillation: A new approach to an old problem

Circulation

Volumn 113, Issue 21, 2006, Pages 2474-2476

  Kwaku, Kevin F ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Atrioventricular node; Editorials; Electrophysiology; Heart rate

Indexed keywords

ATRIOVENTRICULAR CONDUCTION; CELL PROLIFERATION; CELL TRANSPLANTATION; ECHOCARDIOGRAPHY; EDITORIAL; ELECTROSTIMULATION THERAPY; FIBROBLAST; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; REFRACTORY PERIOD; RR INTERVAL; SAFETY; SINUS RHYTHM; TREATMENT INDICATION; ANIMAL; CYTOLOGY; DRUG EFFECT; HEART ATRIOVENTRICULAR NODE; HEART PACING; HUMAN; METHODOLOGY; NOTE; PATHOPHYSIOLOGY; TRANSPLANTATION;

TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALS; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC PACING, ARTIFICIAL; CELL TRANSPLANTATION; FIBROBLASTS; HUMANS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33745176648     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.626689     Document Type: Editorial

References (22)

1. Khasnis A, Jongnarangsin K, Abela G, Veerareddy S, Reddy V, Thakur R. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol. 2005;28:710-721.
2. Blitzer M, Costeas C, Kassotis J, Reiffel JA. Rhythm management in atrial fibrillation: with a primary emphasis on pharmacologic therapy, part 1. Pacing Clin Electrophysiol. 1998;21:590-602.
3. Boriani G, Biffi M, Diemberger I, Martigianni C, Branzi A. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy. Drugs. 2003;63:1489-1509.
4. Piot O, Chauvel C, Lazarus A, Pellerin D, David D, Leneveut-Ledoux L, Guize L, Le Heuzey JY. Effects of a selective A1-adenosine receptor agonist on heart rate and heart rate variability during permanent atrial fibrillation. Pacing Clin Electrophysiol. 1998;21(pt 2):2459-2464.
5. Lerman BB, Ellenbogen KA, Kadish A, Platia E, Stein KM, Markowitz SM, Mittal S, Slotwiner DJ, Scheiner M, Iwai S, Belardinelli L, Jerling M, Shreeniwas R, Wolff AA. Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans. J Cardiovasc Pharmacol Ther. 2001;6:237-245.
6. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. J Interv Card Electrophysiol. 1998;2:121-135.
7. Scheinman MM, Morady F. Nonpharmacological approaches to atrial fibrillation. Circulation. 2001;103:2120-2125.
8. Rodriguez LM, Leunissen J, Hoekstra A, Korteling BJ, Smeets JL, Timmermans C, Vos M, Daemen M, Wellens HJ. Transvenous cold mapping and cryoablation of the AV node in dogs: observations of chronic lesions and comparison to those obtained using radiofrequency ablation. J Cardiovasc Electrophysiol. 1998;9:1055-1061.
9. Curtis AB, Mansour M, Friedl SE, Tomaru T, Barbeau GR, Normann SJ, Abela GS. Modification of atrioventricular conduction using a combined laser-electrode catheter. Pacing Clin Electrophysiol. 1994;17(pt 1):337-348.
10. Wang PJ, Ursell PC, Sosa-Suarez G, Okishige K, Friedman PL. Permanent AV block or modification of AV nodal function by selective AV nodal artery ethanol infusion. Pacing Clin Electrophysiol. 1992;15:779-789.
11. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation. 2000;101:1138-1144.
12. Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF, Lloyd MA, Packer DL, Hodge DO, Gersh BJ, Hammill SC, Shen WK. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 2001;344:1043-1051.
13. Weerasooriya R, Davis M, Powell A, Szili-Torok T, Shah C, Whalley D, Kanagaratnam L, Heddle W, Leitch J, Perks A, Ferguson L, Bulsara M. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol. 2003;41:1697-1702.
14. Rosenqvist M, Bergfeldt L, Haga Y, Ryden J, Ryden L, Owall A. The effect of ventricular activation sequence on cardiac performance during pacing. Pacing Clin Electrophysiol. 1996;19:1279-1286.
15. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, Djiane P, Mabo P, Levy T, Gadler F, Bailleul C, Daubert JC. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J. 2002;23:1780-1787.
16. Simantirakis EN, Vardakis KE, Kochiadakis GE, Manios EG, Igoumenidis NE, Brignole M, Vardas PE. Left ventricular mechanics during right ventricular apical or left ventricular-based pacing ill patients with chronic atrial fibrillation after atrioventricular junction ablation. J Am Coll Cardiol. 2004;43:1013-1018.
17. Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL, Langberg JJ, DeLurgio DB. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol. 2002;39:1258-1263.
18. Williamson BD, Man KC, Daoud E, Niebauer M, Strickberger SA, Morady F. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med. 1994;331:910-917. Erratum N Engl J Med. 1995;332:479.
19. Donahue JK, Heldman AW, Fraser H, McDonald AD, Miller JM, Rade JJ, Eschenhagen T, Marban E. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med. 2000;6:1395-1398.
20. Zhang Y, Yamada H, Bibevski S, Zhuang S, Mowrey KA, Wallick DW, Oh S, Mazgalev TN. Chronic atrioventricular nodal vagal stimulation: first evidence for long-term ventricular rate control in canine atrial fibrillation model. Circulation. 2005;112:2904-2911.
21. Bunch TJ, Mahapatra S, Bruce GK, Johnson SB, Miller DV, Horne BD, Wang X-L, Lee H-C, Caplice NM, Packer DL. Impact of transforming growth factor-β1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. Circulation. 2006;113:2485-2494.
22. Janse MJ, Opthof T, Kléber AG. Animal models of cardiac arrhythmias. Cardiovasc Res. 1998;39:165-177.